SGLT2阻害剤とAKI後の長期的な結果
Anyarin Wannakittirat1,2, Veerapatr Nimkietkajorn3, Peerapat Thanapongsathorn4
1Division of Nephrology, Department of Medicine, Faculty of Medicine, Naresuan University Hospital, Phitsanulok, Thailand.
Kidney international reports
|February 13, 2026
まとめ
ナトリウム・グルコース・コトランスポーター-2阻害剤 (SGLT2i) は,急性腎損傷 (AKI) の生存者における主要な腎臓不良事件 (MAKE365) を減少させなかった. しかし,empagliflozinは,この高リスク集団における再発性AKIエピソードを著しく減少させました.
科学分野:
- ネフロロジーはネフロロジーを用います.
- 循環器内科 循環器内科医学
- クリニック・トライアル 臨床試験
背景:
- 急性腎臓損傷 (AKI) の後の生存者は,腎臓および腎臓以外の不良の結果のリスクが高い.
- 現在,この脆弱な患者グループには特定の治療法はありません.
研究 の 目的:
- 重度のAKIの生存者において1年後の主要な腎不良事件 (MAKE365) を減らすためのナトリウム・グルコースコトランスポーター-2阻害剤 (SGLT2i) の有効性を調査する.
- エムパグリフロジンの再発性AKIへの影響を,AKI後の環境で評価する.
主な方法:
- 200人の重度のAKIの生存者を対象としたマルチセンターランダム化対照試験で,EGFR ≥20ml/min.
- 参加者は1年間,エンパグリフロジン10mg/日またはプラセボを投与された.
- 主なアウトカムはMAKE365で,継続的な腎機能不全,長期透析の必要性,または死亡の複合体でした.
主要な成果:
- エムパグリフロジンは,プラセボと比較してMAKE365を有意に減少させなかった (35%対36%,P=0.82).
- エムパグリフロジン群では,再発性AKIの有意な減少が観察されました (IRR:0.51,P=0.008).
- AKIステージ3が優勢で,かなりの割合が腎置換治療を必要とした.
結論:
- エムパグリフロジンは,重度のAKIの生存者におけるMAKE365の減少という主要なエンドポイントを満たさなかった.
- エムパグリフロジンは,再発性AKIの発生率を減らすのに有意な効果を示した.
- 今後の研究では,高リスク患者のAKI再発を予防するためにSGLT2iを調査する可能性がある.
関連する概念動画
Eukaryotic Transcription Inhibitors
11.1K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.1K
Predicting Reaction Outcomes
11.0K
Kinetics describes the rate and path by which a reaction occurs. In contrast, thermodynamics deals with state functions and describes the properties, behavior, and components of a system. It is not concerned with the path taken by the process and cannot address the rate at which a reaction occurs. Although it does provide information about what can happen during a reaction process, it does not describe the detailed steps of what appears on an atomic or a molecular level. On the other hand,...
11.0K
Outcomes of Glycolysis
107.8K
Nearly all the energy used by cells comes from the bonds that make up complex organic compounds. These organic compounds are broken down into simpler molecules, such as glucose. As a result, cells extract energy from glucose over many chemical reactions—a process called cellular respiration.
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...
107.8K
Long-term Depression
33.4K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
33.4K
Long-term Depression
3.4K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
3.4K
Guidelines for Writing Outcome
4.1K
When developing expected outcomes for a patient care plan, the nurse should adhere to the following recommendations:
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
4.1K


